What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2026-03-30 compared with 2025-03-28 · 42 added, 29 removed, 0 unchanged (100% of the section changed)

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Our Common Stock is currently quoted on The Nasdaq

Capital Market under the symbol “ELAB.” We had 438,987 shares of Common Stock issued and outstanding as of December 31, 2024.

of Capital Stock

As of December 31, 2024, we had 47 holders of

our Common Stock.

Option Grants

As of the date of this Annual Report, options

to purchase an aggregate of 699 Common Stock have been granted and 74 Common Stock have been issued under the 2020 Plan.

transfer agent for our Common Stock is VStock Transfer, LLC.

The transfer agent’s telephone number and address is (212) 828-8436

and 18 Lafayette Place Woodmere, New York 11598.

date, we have not declared or paid any dividends on our Common Stock.

We currently do not anticipate paying any cash dividends in the

foreseeable future on our Common Stock.

Although we intend to retain our earnings, if any, to finance the exploration and growth of our

business, the board of directors of the Company (the “Board) has the discretion to declare and pay dividends in the future.

of dividends in the future will depend upon our earnings, capital requirements, and any other factors that our Board deems relevant.

March 6, 2024, we received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) notifying

the Company that, based on the closing bid price of our Common Stock, for the last 30 consecutive trading days preceding each letter,

we were no longer compliant with the minimum bid price requirement for continued listing on the Nasdaq Capital Market.

Nasdaq Listing

Rule 5450(a)(1) requires listed securities to maintain the Minimum Bid Price Requirement, and Nasdaq Listing Rule 5810(c)(3)(A) provides

that a failure to meet the Minimum Bid Price Requirement exists if the deficiency continues for a period of 30 consecutive trading days.

Sales of Unregistered Securities

Except as set forth below or in a Current Report

on Form 8-K, there were no equity securities of the registrant sold by the registrant during the period covered by this Annual Report

that were not registered under the Securities Act.

reporting companies are not required to provide the information required by this item.

Market for Registrant’s Common

Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Our Common Stock is currently quoted on The Nasdaq Capital Market under

the symbol “ELAB.” We had 1,936,757 shares of Common Stock issued and outstanding as of December 31, 2025 (such number of

Common Stock on a pre-reverse stock split basis, not reflecting the Company’s 1-for-4 reverse stock split which occurred on January

6, 2026 and 1-for-6 reverse stock split which occurred on March 10, 2026.

Holders of Capital Stock

As of December 31, 2025, we had 40 record holders of our Common Stock.

Stock Option Grants

As of December 31, 2025, the Company had no options

outstanding to purchase Common Stock.

As of December 31, 2025, no shares of Common Stock were issued under the 2025 Equity Incentive Plan.

The 2025 Plan superseded the 2020 Plan and outstanding awards made under the 2020 Plan remained outstanding.

As of December 31, 2025,

there were 6 options outstanding from the 2020 Plan.

Transfer Agent

The transfer agent for our Common Stock is VStock

Transfer, LLC.

The transfer agent’s telephone number and address is (212) 828-8436 and 18 Lafayette Place Woodmere, New York 11598.

To date, we have not declared or paid any dividends on our Common Stock.

We currently do not anticipate paying any cash dividends in the foreseeable future on our Common Stock.

Although we intend to retain our

earnings, if any, to finance the exploration and growth of our business, the Board of Directors has the discretion to declare and pay

dividends in the future.

Payment of dividends in the future will depend

upon our earnings, capital requirements, and any other factors that our Board deems relevant.

Nasdaq Compliance

On November 7, 2024,

we received a letter from Nasdaq (the “Bid Price Deficiency Letter”) granting an exception for us to cure our lack of compliance

with the bid price requirement in Listing Rule 5550(a)(2) (such rule, the “Bid Price Rule,” and such deficiency of the Bid

Price Rule, the “Bid Price Deficiency”).

In the Bid Price Deficiency Letter, Nasdaq permitted our continued listing on Nasdaq

on the conditions that:

(1) on or before December 26, 2024, we complete a reverse split at a ratio sufficient to maintain long-term compliance

with the Bid Price Rule;

and (2) on or before January 9, 2025, we demonstrate compliance with the Bid Price Rule.

On January 14, 2025,

the Company received a letter from Nasdaq (“Compliance Letter”) stating the Company had demonstrated compliance with the Bid

Recent Sales of Unregistered Securities

There were no equity securities of the registrant

sold by the registrant during the period covered by this Annual Report that were not registered under the Securities Act.

Not applicable.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity